Breaking down the barriers: siRNA delivery and endosome escape

Monika Dominska, Derek M Dykxhoorn

Research output: Contribution to journalArticle

373 Citations (Scopus)

Abstract

RNA interference (RNAi)-based technologies offer an attractive strategy for the sequence-specific silencing of disease-causing genes. The application of small interfering (si)RNAs as potential therapeutic agents requires safe and effective methods for their delivery to the cytoplasm of the target cells and tissues. Recent studies have shown significant progress in the development of targeting reagents that facilitate the recognition of and siRNA delivery to specific cell types. However, most of these delivery approaches are not optimized to enable the intracellular trafficking of the siRNAs into the cytoplasm where they must associate with the RNA-induced silencing complex (RISC) to direct the cleavage of mRNAs bearing complementary binding sites. In particular, the trafficking of siRNAs from endosomes into the cytoplasm represents a major rate-limiting step for many delivery approaches. This Commentary focuses on novel strategies designed to enhance endosomal escape and thereby increase the efficacy of siRNA-mediated gene silencing.

Original languageEnglish
Pages (from-to)1183-1189
Number of pages7
JournalJournal of Cell Science
Volume123
Issue number8
DOIs
StatePublished - Apr 15 2010

Fingerprint

Endosomes
Small Interfering RNA
Cytoplasm
RNA-Induced Silencing Complex
Gene Silencing
RNA Interference
Binding Sites
Technology
Messenger RNA
Genes
Therapeutics

Keywords

  • Gene silencing
  • RNA interference
  • siRNA delivery
  • siRNA trafficking

ASJC Scopus subject areas

  • Cell Biology

Cite this

Breaking down the barriers : siRNA delivery and endosome escape. / Dominska, Monika; Dykxhoorn, Derek M.

In: Journal of Cell Science, Vol. 123, No. 8, 15.04.2010, p. 1183-1189.

Research output: Contribution to journalArticle

@article{8d3a46ad1a374d349bd9432b3446ddf4,
title = "Breaking down the barriers: siRNA delivery and endosome escape",
abstract = "RNA interference (RNAi)-based technologies offer an attractive strategy for the sequence-specific silencing of disease-causing genes. The application of small interfering (si)RNAs as potential therapeutic agents requires safe and effective methods for their delivery to the cytoplasm of the target cells and tissues. Recent studies have shown significant progress in the development of targeting reagents that facilitate the recognition of and siRNA delivery to specific cell types. However, most of these delivery approaches are not optimized to enable the intracellular trafficking of the siRNAs into the cytoplasm where they must associate with the RNA-induced silencing complex (RISC) to direct the cleavage of mRNAs bearing complementary binding sites. In particular, the trafficking of siRNAs from endosomes into the cytoplasm represents a major rate-limiting step for many delivery approaches. This Commentary focuses on novel strategies designed to enhance endosomal escape and thereby increase the efficacy of siRNA-mediated gene silencing.",
keywords = "Gene silencing, RNA interference, siRNA delivery, siRNA trafficking",
author = "Monika Dominska and Dykxhoorn, {Derek M}",
year = "2010",
month = "4",
day = "15",
doi = "10.1242/jcs.066399",
language = "English",
volume = "123",
pages = "1183--1189",
journal = "Journal of Cell Science",
issn = "0021-9533",
publisher = "Company of Biologists Ltd",
number = "8",

}

TY - JOUR

T1 - Breaking down the barriers

T2 - siRNA delivery and endosome escape

AU - Dominska, Monika

AU - Dykxhoorn, Derek M

PY - 2010/4/15

Y1 - 2010/4/15

N2 - RNA interference (RNAi)-based technologies offer an attractive strategy for the sequence-specific silencing of disease-causing genes. The application of small interfering (si)RNAs as potential therapeutic agents requires safe and effective methods for their delivery to the cytoplasm of the target cells and tissues. Recent studies have shown significant progress in the development of targeting reagents that facilitate the recognition of and siRNA delivery to specific cell types. However, most of these delivery approaches are not optimized to enable the intracellular trafficking of the siRNAs into the cytoplasm where they must associate with the RNA-induced silencing complex (RISC) to direct the cleavage of mRNAs bearing complementary binding sites. In particular, the trafficking of siRNAs from endosomes into the cytoplasm represents a major rate-limiting step for many delivery approaches. This Commentary focuses on novel strategies designed to enhance endosomal escape and thereby increase the efficacy of siRNA-mediated gene silencing.

AB - RNA interference (RNAi)-based technologies offer an attractive strategy for the sequence-specific silencing of disease-causing genes. The application of small interfering (si)RNAs as potential therapeutic agents requires safe and effective methods for their delivery to the cytoplasm of the target cells and tissues. Recent studies have shown significant progress in the development of targeting reagents that facilitate the recognition of and siRNA delivery to specific cell types. However, most of these delivery approaches are not optimized to enable the intracellular trafficking of the siRNAs into the cytoplasm where they must associate with the RNA-induced silencing complex (RISC) to direct the cleavage of mRNAs bearing complementary binding sites. In particular, the trafficking of siRNAs from endosomes into the cytoplasm represents a major rate-limiting step for many delivery approaches. This Commentary focuses on novel strategies designed to enhance endosomal escape and thereby increase the efficacy of siRNA-mediated gene silencing.

KW - Gene silencing

KW - RNA interference

KW - siRNA delivery

KW - siRNA trafficking

UR - http://www.scopus.com/inward/record.url?scp=77951168054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951168054&partnerID=8YFLogxK

U2 - 10.1242/jcs.066399

DO - 10.1242/jcs.066399

M3 - Article

C2 - 20356929

AN - SCOPUS:77951168054

VL - 123

SP - 1183

EP - 1189

JO - Journal of Cell Science

JF - Journal of Cell Science

SN - 0021-9533

IS - 8

ER -